Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor

Cancer Discovery

Volumn 3, Issue 6, 2013, Pages 648-657

  Killian, J Keith ^a   Kim, Su Young ^a   Miettinen, Markku ^a   Smith, Carly ^a   Merino, Maria ^a   Tsokos, Maria ^a   Quezado, Martha ^a   Smith, William I ^b   Jahromi, Mona S ^d   Xekouki, Paraskevi ^c   Szarek, Eva ^c   Walker, Robert L ^a   Lasota, Jerzy ^a   Raffeld, Mark ^a   Klotzle, Brandy ^e   Wang, Zengfeng ^a   Jones, Laura ^a   Zhu, Yuelin ^a   Wang, Yonghong ^a   Waterfall, Joshua J ^a   O'Sullivan, Maureen J ^g   Bibikova, Marina ^e   Pacak, Karel ^c   Stratakis, Constantine ^c   Janeway, Katherine A ^f   Schiffman, Joshua D ^d   Fan, Jian Bing ^e   Helman, Lee ^a   Meltzer, Paul S ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SUBURBAN HOSPITAL   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e ILLUMINA INC   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; ISOCITRATE DEHYDROGENASE; PROTEIN TYROSINE KINASE; SUCCINATE DEHYDROGENASE;

ARTICLE; CARCINOGENESIS; CITRIC ACID CYCLE; CONTROLLED STUDY; DNA LIBRARY; DNA METHYLATION; EPIGENETICS; GASTROINTESTINAL STROMAL TUMOR; GENE DOSAGE; GENE MUTATION; GENOMIC INSTABILITY; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRINCIPAL COMPONENT ANALYSIS;

EID: 84878152241     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-13-0092     Document Type: Article

References (26)

1. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, etal. Identifi cation of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010;17: 510-22.
2. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, etal. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010;18:553-67.
3. Pansuriya TC, van Eijk R, d'Adamo P, van Ruler MA, Kuijjer ML, Oosting J, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 2011;43:1256-61.
4. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-80.
5. Pantaleo MA, Astolfi A, Indio V, Moore R, Thiessen N, Heinrich MC, et al. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J Natl Cancer Inst 2011;103:983-7.
6. Janeway KA, Kim SY, Lodish M, Nose V, Rustin P, Gaal J, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA 2011;108:314-8.
7. Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, et al. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol 2013;37:234-40.
8. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007;5:S1-29; quiz S30.
9. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 2005;5:857-66.
10. Frezza C, Pollard PJ, Gottlieb E. Inborn and acquired metabolic defects in cancer. J Mol Med 2011;89:213-20.
11. Cervera AM, Bayley JP, Devilee P, McCreath KJ. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer 2009;8:89.
12. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 2012;26:1326-38.
13. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006;130:1466-78.
14. Rosai J. Gastrointestinal stromal tumor and its mimics. Int J Surg Pathol 2010;18:79S-87S.
15. Rosai J. GIST: an update. Int J Surg Pathol 2003;11:177-86.
16. Min KW. Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis. Ultrastruct Pathol 2010;34:174-88.
17. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012;150:1135-46.
18. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010;463:899-905.
19. Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, et al. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer 2009;48:886-96.
20. Astolfi A, Nannini M, Pantaleo MA, Di Battista M, Heinrich MC, Santini D, et al. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and highresolution genomic copy number. Lab Invest 2010;90:1285-94.
21. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, etal. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005;7:77-85.
22. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008;8:705-13.
23. Killian JK, Bilke S, Davis S, Walker RL, Jaeger E, Killian MS, et al. A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology. Am J Pathol 2011;179: 55-65.
24. Killian JK, Bilke S, Davis S, Walker RL, Killian MS, Jaeger EB, etal. Largescale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res 2009;69:758-64.
25. Bibikova M, Fan JB. GoldenGate assay for DNA methylation profiling. Methods Mol Biol 2009;507:149-63.
26. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, etal. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 2009;1:177-200.